Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
New words:
absorption, accuracy, add, advisor, Aevi, agrobiotech, Alcobra, Alrov, andfinancial, Andrew, aperformance, Aposense, Asia, assumption, automatically, Azilect, BA, bachelor, background, Bar, Barcode, Ben, Berkeley, Bezeq, Bio, Biochemist, BiolineRx, biomaterial, Biomedix, BioPharma, blocker, bound, BRIGHT, Brill, Bronfeld, bundle, bundled, businessman, California, Cambrex, Camp, car, carryforward, carryover, CC, charter, Chicago, chose, Citigroup, Club, Colbar, College, Command, Commanding, commercializingalfataliglicerasein, confirmatory, contested, Contipi, Copaxone, count, CPA, creatinine, curve, David, decade, deem, deemed, delegation, Deputy, descent, device, Dexxon, Disallowed, discretionary, dissolution, distinct, Division, domestic, Dr, dropout, EBC, EBIT, EBITDA, Electreon, Electrical, Emerging, employeewhose, endoscopy, Entera, ENTX, epidemiologic, equitability, equitable, erosion, Excellence, excessive, exhaustive, FDASIA, Fellow, fifty, Floor, Foamix, forty, futuremanufacturing, Geometrix, George, Geregu, gift, GLEA, goal, Golden, goodsat, graduate, Granot, Greenwich, Gurion, Haifa, Harel, Harvard, healing, Herzliya, Hewlett, Highbridge, Highcon, Holdco, home, honorary, hypothecated, Idanit, IDC, identification, IIb, image, implicated, improper, Incubator, indefinite, indefinitely, indirect, interdependent, Interdisciplinary, interlocking, intermediate, interrelated, IP, Irish, irreversible, Jersey, job, joined, joining, Kevin, laptop, Leap, lieu, LifeScience, lifetime, Light, literacy, LLC, Macrocure, Makor, marginal, marker, Martin, master, Max, MBA, median, Mediline, membership, merger, MEway, MIGAL, millionin, mitigation, molecular, mucosal, NDU, nonemployee, Nostro, Noteswere, NY, Objet, offeror, opportunity, optionee, Ormat, outlicensed, overseen, Pacific, Packard, pathophysiologic, pathway, PDL, PDLI, peace, peer, PEO, Perlman, Perrigo, perspective, Pfizerat, Pharma, philosophy, phone, plc, pool, possessing, possession, Postdoctoral, proceed, prognostic, properly, prudent, qualitative, Quinpario, radiographic, realign, recreational, repatriation, repeal, repealed, reputation, reputational, Respectfully, Retaliation, retention, River, Russell, Sagent, School, Scitex, sequelae, Shalev, Shepherdstown, sinceChiesi, Snunit, Southern, SOX, split, startup, Steam, subpart, Subtopic, successor, Sun, surrogate, Tadiran, Takeda, talented, Task, taxation, TDA, Technorov, Telecommunication, Templeton, Tempo, tender, tenure, teva, TGF, theFDA, theresearch, thought, tie, toIsrael, TransBiodiesel, Turkish, Twine, UBS, vast, Velox, venture, verify, Verisity, Vice, Vision, vocational, Wacker, Washington, West, whichcould, whichwould, Wye, Yaron, Yodfat, Zeev
Filing tables
Filing exhibits
Related press release
Associated PLX transcripts
PLX similar filings
Filing view
External links
Exhibit23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (No. 333-148983, No. 333-182677, No. 333-203960 and No. 333-225526) of Protalix BioTherapeutics, Inc. of our report dated March 14, 2019, relating to the financial statements and the effectiveness of internal control over financial reporting, which appears in this Form 10-K.
/s/ Kesselman & Kesselman | |
Kesselman & Kesselman | |
Certified Public Accountants (lsr.) | |
A member firm of PricewaterhouseCoopers International Limited |
Tel-Aviv, Israel
March 14, 2019